tiprankstipranks
Trending News
More News >
Encompass Health (EHC)
NYSE:EHC
US Market
Advertisement

Encompass Health (EHC) Earnings Dates, Call Summary & Reports

Compare
402 Followers

Earnings Data

Report Date
Oct 22, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
1.2
Last Year’s EPS
1.03
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call for Encompass Health's second quarter of 2025 presented a strong performance with significant increases in revenue and EBITDA, impressive discharge growth, and successful expansion efforts. However, challenges remain in managing benefits expenses and labor retention. Despite these challenges, the overall sentiment is positive due to the substantial financial growth and strategic expansions.
Company Guidance
During the second quarter of 2025, Encompass Health reported significant improvements across various key metrics. The company achieved a 12% increase in revenue, reaching $1.46 billion, and a 17.2% rise in adjusted EBITDA to $308.6 million. Discharge growth was robust at 7.2%, with same-store discharges up by 4.7%. Particularly noteworthy was the 12% growth in neurological conditions and a 6.7% increase in stroke cases. The discharge to community rate was favorable at 8.5%, and the discharge to SNF rate was 5.8%, both surpassing industry averages. The company opened new facilities, including a 60-bed hospital in Fort Myers and a 50-bed hospital in Daytona Beach, with plans to open additional hospitals by year's end. Adjusted free cash flow saw a 30.5% increase to $186 million for the quarter, contributing to a strong year-to-date total of $408 million, a 31.7% improvement from the previous year. Encompass Health also revised its 2025 guidance upward, now expecting net operating revenue of $5.88 billion to $5.98 billion, adjusted EBITDA of $1.22 billion to $1.25 billion, and adjusted earnings per share between $5.12 and $5.34.
Strong Revenue and EBITDA Growth
Revenue for the second quarter increased 12% to $1.46 billion, and adjusted EBITDA increased 17.2% to $308.6 million.
Positive Discharge Growth
Total discharges for Q2 increased 7.2%, including 4.7% in same-store. Neurological conditions and stroke discharges grew 12% and 6.7%, respectively.
Expansion and New Hospital Openings
In Q2, a new 60-bed hospital was opened in Fort Myers, Florida, and 26 beds were added to an existing hospital. In July, a new 50-bed hospital was opened in Daytona Beach, Florida, and 20 beds were added to another existing hospital.
Improved Labor Costs
Contract labor and sign-on and shift bonuses declined by $4.9 million or 15.1%, with contract labor FTEs representing 1.3% of total FTEs.
Increased 2025 Guidance
The company raised its 2025 guidance with net operating revenue expected to be $5.88 billion to $5.98 billion, adjusted EBITDA of $1.22 billion to $1.25 billion, and adjusted earnings per share of $5.12 to $5.34.
Strong Free Cash Flow Growth
Q2 adjusted free cash flow increased 30.5% to approximately $186 million, bringing year-to-date adjusted free cash flow to approximately $408 million, a 31.7% increase from the first half of 2024.

Encompass Health (EHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2025
2025 (Q3)
1.20 / -
1.03
Aug 04, 2025
2025 (Q2)
1.23 / 1.40
1.1126.13% (+0.29)
Apr 24, 2025
2025 (Q1)
1.19 / 1.37
1.1222.32% (+0.25)
Feb 06, 2025
2024 (Q4)
1.02 / 1.17
0.9523.16% (+0.22)
Oct 28, 2024
2024 (Q3)
0.94 / 1.03
0.8619.77% (+0.17)
Aug 05, 2024
2024 (Q2)
1.01 / 1.11
0.9516.84% (+0.16)
Apr 24, 2024
2024 (Q1)
0.94 / 1.12
0.8827.27% (+0.24)
Feb 07, 2024
2023 (Q4)
0.82 / 0.95
0.887.95% (+0.07)
Oct 26, 2023
2023 (Q3)
0.78 / 0.86
0.6728.36% (+0.19)
Aug 01, 2023
2023 (Q2)
0.74 / 0.95
0.896.74% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 04, 2025
$109.50$113.88+4.00%
Apr 24, 2025
$101.27$113.21+11.79%
Feb 06, 2025
$98.30$99.55+1.27%
Oct 28, 2024
$92.63$99.51+7.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Encompass Health (EHC) report earnings?
Encompass Health (EHC) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).
    What is Encompass Health (EHC) earnings time?
    Encompass Health (EHC) earnings time is at Oct 22, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EHC EPS forecast?
          EHC EPS forecast for the fiscal quarter 2025 (Q3) is 1.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis